Article(id=1325223668728603157, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223620166943241, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2026.05.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1745769600000, receivedDateStr=2025-04-28, revisedDate=1762876800000, revisedDateStr=2025-11-12, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887544089, onlineDateStr=2026-11-05, pubDate=1778342400000, pubDateStr=2026-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887544089, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887544089, creator=13701087609, updateTime=1793887544089, updator=13701087609, issue=Issue{id=1325223620166943241, tenantId=1146029695717560320, journalId=1319690329412173987, year='2026', volume='47', issue='5', pageStart='455', pageEnd='588', issueExtLink='null', onlineDate='null', pubDate='1778342400000', pubDateStr='2026-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887532512, creator='13701087609', updateTime=1793934786637, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325421818395361842, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223620166943241, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325421818395361843, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223620166943241, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=455, endPage=461, ext={EN=ArticleExt(id=1325223668938318358, articleId=1325223668728603157, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Application and progress of hotspot drugs in immunotherapy for immunoglobulin A nephropathy, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=
Immunoglobulin A nephropathy(IgAN) is the primary glomerular disease that leads to end-stage renal disease(ESRD), 40% of IgAN patients have progressed to ESRD within 20 years after diagnosis, and it is a common cause of renal failure among young people in China. The current supportive treatment, corticosteroids, and non-specific immunosuppressants have limited effects. New therapies targeting the specific mechanisms of IgAN are urgently needed.This article reviewed the latest progress of hot drugs for IgAN immunotherapy, including B-cell-targeting drugs and complement-targeting drugs, focusing on related pharmacology, clinical research and safety, in order to provide references for research and application.
, authors=Yongli LIANG, Dan WU, Lixin ZHANG, Huaile ZHONG, Guleng Siri
*, authorsList=Yongli LIANG, Dan WU, Lixin ZHANG, Huaile ZHONG, Guleng Siri, authorCompany=null, correspAuthors=Guleng Siri, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325223669282251287, articleId=1325223668728603157, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=免疫球蛋白A肾病免疫治疗热点药物的应用与进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=
免疫球蛋白A肾病(immunoglobulin A nephropathy,IgAN)是导致终末期肾病(end-stage renal disease,ESRD)的主要原发性肾小球疾病,40%的IgAN患者在确诊后20年内发展至ESRD,是引起我国青年人群肾衰竭的常见病因。支持性治疗、皮质类固醇及非特异性免疫抑制剂等现有疗法效果有限,亟需开发针对IgAN特异性机制的新型疗法。现综述B细胞靶向药物、补体靶向药物等IgAN免疫治疗热点药物最新进展,重点介绍相关药理学、临床研究及安全性,以期为肾疾病的临床治疗提供参考。
, authors=梁永利, 乌丹, 张丽新, 钟怀乐, 斯日古楞
*, authorsList=梁永利, 乌丹, 张丽新, 钟怀乐, 斯日古楞, authorCompany=null, correspAuthors=斯日古楞, authorNote=
, correspAuthorsNote=
斯日古楞,主任药师,研究方向:临床药学及药事管理。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=QFuDsUdgUsTStyDLcz1Khg==, magXml=2DYekEtJ1l/90JteAfugeg==, pdfUrl=null, pdf=l6QPXXkGHvU3b7ij93m+6w==, pdfFileSize=978826, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=orx7vUkfFp++XK34FrHSfQ==, mapNumber=null, fund=null)}, authors=[Author(id=1325223669697487388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223669798150686, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, authorId=1325223669697487388, language=EN, stringName=Yongli LIANG, firstName=Yongli, middleName=null, lastName=LIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223669898813983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, authorId=1325223669697487388, language=CN, stringName=梁永利, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学部,内蒙古 呼和浩特 010017, bio={"content":"
梁永利,副主任药师,研究方向:肾脏病合理用药。
"}, bioImg=null, bioContent=
梁永利,副主任药师,研究方向:肾脏病合理用药。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223669491966488, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, xref=null, ext=[AuthorCompanyExt(id=1325223669504549401, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1325223669508743706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学部,内蒙古 呼和浩特 010017)])]), Author(id=1325223670087557665, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223670192415267, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, authorId=1325223670087557665, language=EN, stringName=Dan WU, firstName=Dan, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223670280495652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, authorId=1325223670087557665, language=CN, stringName=乌丹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学部,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223669491966488, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, xref=null, ext=[AuthorCompanyExt(id=1325223669504549401, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1325223669508743706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学部,内蒙古 呼和浩特 010017)])]), Author(id=1325223670368576038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223670473433640, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, authorId=1325223670368576038, language=EN, stringName=Lixin ZHANG, firstName=Lixin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223670620234281, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, authorId=1325223670368576038, language=CN, stringName=张丽新, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学部,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223669491966488, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, xref=null, ext=[AuthorCompanyExt(id=1325223669504549401, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1325223669508743706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学部,内蒙古 呼和浩特 010017)])]), Author(id=1325223670725091883, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223670829949485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, authorId=1325223670725091883, language=EN, stringName=Huaile ZHONG, firstName=Huaile, middleName=null, lastName=ZHONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223672612528686, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, authorId=1325223670725091883, language=CN, stringName=钟怀乐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=内蒙古自治区人民医院药学部,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223669491966488, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, xref=null, ext=[AuthorCompanyExt(id=1325223669504549401, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1325223669508743706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学部,内蒙古 呼和浩特 010017)])]), Author(id=1325223672708997680, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223672805466674, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, authorId=1325223672708997680, language=EN, stringName=Guleng Siri, firstName=Guleng, middleName=null, lastName=Siri, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223672922907187, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, authorId=1325223672708997680, language=CN, stringName=斯日古楞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=内蒙古自治区人民医院药学部,内蒙古 呼和浩特 010017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223669491966488, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, xref=null, ext=[AuthorCompanyExt(id=1325223669504549401, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1325223669508743706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学部,内蒙古 呼和浩特 010017)])])], keywords=[Keyword(id=1325223673048736308, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, language=EN, orderNo=1, keyword=immunoglobulin A nephropathy), Keyword(id=1325223673166176821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, language=EN, orderNo=2, keyword=glomerulonephritis), Keyword(id=1325223673463972406, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, language=EN, orderNo=3, keyword=B-cell-targeting drug), Keyword(id=1325223673577218615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, language=EN, orderNo=4, keyword=complement-targeting drug), Keyword(id=1325223673690464824, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, language=EN, orderNo=5, keyword=immunotherapy), Keyword(id=1325223673770156601, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, language=CN, orderNo=1, keyword=免疫球蛋白A肾病), Keyword(id=1325223673883402810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, language=CN, orderNo=2, keyword=肾小球肾炎), Keyword(id=1325223673988260411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, language=CN, orderNo=3, keyword=B细胞靶向药物), Keyword(id=1325223674076340796, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, language=CN, orderNo=4, keyword=补体靶向药物), Keyword(id=1325223674168615485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, language=CN, orderNo=5, keyword=免疫治疗)], refs=[Reference(id=1325223674336387646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=杜夕雯, 肖敦明, 敖超群, 等. 中国 IgAN 成人疾病负担[J].中国药物经济学, 2022, 17(7): 46-52., articleTitle=null, refAbstract=null), Reference(id=1325223674428662335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=SHEN X, CHEN P, LIU M,
et al. Long-term outcomes of IgA nephropathy in China[J]. Nephrol Dial Transplant, 2025,40(6): 1137-1146., articleTitle=null, refAbstract=null), Reference(id=1325223674516742720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=PITCHER D, BRADDON F, HENDRY B,
et al. Long-term outcomes in IgA nephropathy[J]. Clin J Am Soc Nephrol,2023, 18(6): 727-738., articleTitle=null, refAbstract=null), Reference(id=1325223674713875009, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=中国医药卫生文化协会肾病与血液净化专业委员会. 原发性 IgAN 管理和治疗中国专家共识[J]. 中华肾病研究电子杂志, 2024, 13(1): 1-8., articleTitle=null, refAbstract=null), Reference(id=1325223674793566786, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=GESUALDO L, di LEO V, COPPO R. The mucosal immune system and IgA nephropathy[J]. Semin Immunopathol, 2021,43(5): 657-668., articleTitle=null, refAbstract=null), Reference(id=1325223674869064259, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=LAFAYETTE R, KRISTENSEN J, STONE A,
et al. Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy(NefIgArd):2-year results from a randomised phase 3 trial[J]. Lancet,402(10405): 859-870., articleTitle=null, refAbstract=null), Reference(id=1325223674957144644, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=BARRATT J, LAFAYETTE R, KRISTENSEN J,
et al.Results from part A of the multi-center, double-blind,randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy[J].Kidney Int, 2023, 103(2): 391-402., articleTitle=null, refAbstract=null), Reference(id=1325223675036836421, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=BARRATT J, KRISTENSEN J, PEDERSEN C,
et al. Insights on Nefecon
®, a targeted-release formulation of budesonide and its selective immunomodulatory effects in patients with IgA nephropathy[J]. Drug Des Devel Ther, 2024, 18: 3415-3428., articleTitle=null, refAbstract=null), Reference(id=1325223675192025670, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=CAO Y, LU G, CHEN X,
et al. BAFF is involved in the pathogenesis of IgA nephropathy by activating the TRAF6/NF-κB signaling pathway in glomerular mesangial cells[J].Mol Med Rep, 2020, 21(2): 795-805., articleTitle=null, refAbstract=null), Reference(id=1325223675280106055, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEUNG CK, BARRATT J, CARROLL K,
et al. Targeting APRIL in the treatment of IgA nephropathy[J]. Clin J Am Soc Nephrol, 2024, 19(3): 394-398., articleTitle=null, refAbstract=null), Reference(id=1325223677234651720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEUNG CK, BARRATT J, LIEW A,
et al. The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies[J]. Front Nephrol, 2024,3: 1346769., articleTitle=null, refAbstract=null), Reference(id=1325223677335315017, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ZAN J, LIU L, LI G,
et al. Effect of telitacicept on circulating Gd-IgA1 and IgA-containing immune complexes in IgA nephropathy[J]. Kidney Int Rep, 2024, 9(4): 1067-1071., articleTitle=null, refAbstract=null), Reference(id=1325223677645693514, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=LVY J, LIU L, HAO C,
et al. Randomized phase 2 trial of telitacicept in patients with IgA nephropathy with persistent proteinuria[J]. Kidney Int Rep, 2022, 8(3): 499-506., articleTitle=null, refAbstract=null), Reference(id=1325223677758939723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=LAFAYETTE R, BARBOUR S, ISRANI R,
et al. A phase 2b,randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy[J]. Kidney Int,2024, 105(6): 1306-1315., articleTitle=null, refAbstract=null), Reference(id=1325223678073512524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=DAVIES R, PENG SL, LICKLITER J,
et al. A first-in-human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults[J]. Clin Transl Sci,2024, 17(11): e70055., articleTitle=null, refAbstract=null), Reference(id=1325223678144815693, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=MADAN A, YALAVARTHY R, KIM DK,
et al.Povetacicept for IgA nephropathy and primary membranous nephropathy[J]. Kidney Int Rep, 2025, 11(1): 106-116., articleTitle=null, refAbstract=null), Reference(id=1325223678270644814, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=DOGGRELL SA. Sibeprenlimab, which neutralizes A proliferation inducing ligand(APRIL), as a new approach to treating IgA nephropathy[J]. Expert Opin Biol Ther, 2024,24(5): 335-338., articleTitle=null, refAbstract=null), Reference(id=1325223678568440399, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=MATHUR M, BARRATT J, SUZUKI Y,
et al. Safety,tolerability, pharmacokinetics, and pharmacodynamics of VIS649(Sibeprenlimab), an APRIL-neutralizing IgG2 monoclonal antibody, in healthy volunteers[J]. Kidney Int Rep, 2022, 7(5): 993-1003., articleTitle=null, refAbstract=null), Reference(id=1325223678895596112, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=MATHUR M, BARRATT J, CHACKO B,
et al. A phase 2 trial of sibeprenlimab in patients with IgA nephropathy[J]. N Engl J Med, 2024, 390(1): 20-31., articleTitle=null, refAbstract=null), Reference(id=1325223679004648017, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=YEO SC, BARRATT J. The contribution of a proliferation-inducing ligand(APRIL) and other TNF superfamily members in pathogenesis and progression of IgA nephropathy[J]. Clin Kidney J, 2023, 16(Suppl 2): ii9-ii18., articleTitle=null, refAbstract=null), Reference(id=1325223679327609426, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=KOOIENGA L, LO J, LEE EY,
et al. Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathy[J]. Kidney Int,2025, 108(3): 445-454., articleTitle=null, refAbstract=null), Reference(id=1325223679424078419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=WILLIAMS CEC, LAMOND M, MARRO J,
et al. A narrative review of potential drug treatments for nephritis in children with IgA vasculitis(HSP)[J]. Clin Rheumatol, 2023,42(12): 3189-3200., articleTitle=null, refAbstract=null), Reference(id=1325223679747039828, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=LAFAYETTE RA, CANETTA PA, ROVIN BH,
et al. A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction[J]. J Am Soc Nephrol,2017, 28(4): 1306-1313., articleTitle=null, refAbstract=null), Reference(id=1325223681462510165, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=FLOEGE J. Glomerular disease: rituximab therapy for IgA nephropathy[J]. Nat Rev Nephrol, 2017, 13(3): 138-140., articleTitle=null, refAbstract=null), Reference(id=1325223681567367766, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=CHIARENZA DS, VERRINA EE, LA PORTA E,
et al.Biologics and non-biologics immunosuppressive treatments for IgA nephropathy in both adults and children[J]. J Clin Med, 2024, 13(9): 2465., articleTitle=null, refAbstract=null), Reference(id=1325223681844191831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=CHANCHAROENTHANA W, LEELAHAVANICHKUL A,ARIYANON W,
et al. Comparative long-term renal allograft outcomes of recurrent immunoglobulin a with severe activity in kidney transplant recipients with and without rituximab:an observational cohort study[J]. J Clin Med, 2021, 10(17):3939., articleTitle=null, refAbstract=null), Reference(id=1325223681944855128, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=LI J, NIE Z, LI G,
et al. Efficacy and safety of rituximab in primary IgA nephropathy: a retrospective study[J]. Clin Exp Nephrol, 2025, 29(5): 616-623., articleTitle=null, refAbstract=null), Reference(id=1325223682041324121, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=FLOEGE J, LAFAYETTE R, BARRATT J,
et al.Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy[J]. Kidney Int, 2025, 108(4): 695-706., articleTitle=null, refAbstract=null), Reference(id=1325223682343314010, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=HARTONO C, CHUNG M, PERLMAN AS,
et al. Bortezomib for reduction of proteinuria in IgA nephropathy[J]. Kidney Int Rep, 2018, 3(4): 861-866., articleTitle=null, refAbstract=null), Reference(id=1325223682431394395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=李贵森. 靶向补体的 IgAN 治疗进展[J]. 实用医院临床杂志, 2024, 21(1): 23-25., articleTitle=null, refAbstract=null), Reference(id=1325223682540446300, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=LAFAYETTE RA, ROVIN BH, REICH HN,
et al. Safety,tolerability and efficacy of narsoplimab, a novel MASP-2 inhibitor for the treatment of IgA nephropathy[J]. Kidney Int Rep, 2020, 5(11): 2032-2041., articleTitle=null, refAbstract=null), Reference(id=1325223682641109597, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=PERKOVIC V, TRIMARCHI H, TESAR V,
et al.Sibeprenlimab in IgA nephropathy-interim analysis of a phase 3 trial[J]. N Engl J Med, 2026, 394(7): 635-646., articleTitle=null, refAbstract=null), Reference(id=1325223682720801374, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=LAFAYETTE R, TUMLIN J, FENOGLIO R,
et al. Efficacy and safety of ravulizumab in IgA nephropathy: a phase 2 randomized double-blind placebo-controlled trial[J]. J Am Soc Nephrol, 2025, 36(4): 645-656., articleTitle=null, refAbstract=null), Reference(id=1325223682855019103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=BARRATT J, LIEW A, YEO SC,
et al. Phase 2 trial of cemdisiran in adult patients with IgA nephropathy: a randomized controlled trial[J]. Clin J Am Soc Nephrol, 2024,19(4): 452-462., articleTitle=null, refAbstract=null), Reference(id=1325223682968265312, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE A. Avacopan: first approval[J]. Drugs, 2022, 82(1): 79-85., articleTitle=null, refAbstract=null), Reference(id=1325223683064734305, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=BRUCHFELD A, MAGIN H, NACHMAN P,
et al.C5a receptor inhibitor avacopan in immunoglobulin A nephropathy: an open-label pilot study[J]. Clin Kidney J,2022, 15(5): 922-928., articleTitle=null, refAbstract=null), Reference(id=1325223683190563426, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG H, RIZK DV, PERKOVIC V,
et al. Results of a randomized double-blind placebo-controlled phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy[J]. Kidney Int, 2024, 105(1):189-199., articleTitle=null, refAbstract=null), Reference(id=1325223683274449507, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=PERKOVIC V, BARRATT J, ROVIN B,
et al. Alternative complement pathway inhibition with iptacopan in IgA nephropathy[J]. N Engl J Med, 2025, 392(6): 531-543., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1325223669491966488, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, xref=null, ext=[AuthorCompanyExt(id=1325223669504549401, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China), AuthorCompanyExt(id=1325223669508743706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223668728603157, companyId=1325223669491966488, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=内蒙古自治区人民医院药学部,内蒙古 呼和浩特 010017)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.05.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.05.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2026.05.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2026.05.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1778342400000, fullTextJson=null, articleText=null, reference=null)